Quality and Efficacy Concerns with Generics in Treatment of Hepatitis C with Directly Acting Antivirals
Treating hepatitis C has never been so convenient after the advent of Directly Acting Antivirals (DAA). Convenience is at both ends; for the doctors to prescribe and for patients to comply due to all oral therapy with few adverse effects. Many are already in market, these include, Sofosbuvir, Decla...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dow University of Health Sciences
2017-08-01
|
| Series: | Journal of the Dow University of Health Sciences |
| Online Access: | https://jduhs.com/index.php/jduhs/article/view/1381 |